• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜后淋巴结清扫术后临床Ⅰ期非精原细胞瘤性生殖细胞睾丸肿瘤的原始和复查的血管侵犯和其他预后参数的一致性和预测能力。

Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.

机构信息

Testis Surgery Unit, Surgery Department, Istituto Nazionale dei Tumori, Milano, Italy.

出版信息

J Urol. 2011 Oct;186(4):1298-302. doi: 10.1016/j.juro.2011.05.070. Epub 2011 Aug 17.

DOI:10.1016/j.juro.2011.05.070
PMID:21849196
Abstract

PURPOSE

We reviewed the slides of patients with clinical stage I nonseminomatous germ cell testicular tumors who underwent retroperitoneal lymph node dissection to evaluate the concordance between original and reviewed vascular invasion status, and other histological correlates.

MATERIALS AND METHODS

Between 2002 and 2007 at our institution 202 consecutive patients underwent retroperitoneal lymph node dissection. We requested the slides of 183 patients who underwent orchiectomy elsewhere. The risk of nodal metastasis was considered high in those with vascular invasion and/or greater than 90% embryonal carcinoma, and low in those with no vascular invasion and embryonal carcinoma less than 90%. Using Cohen's κ we assessed the concordance index between original and reviewed parameters (vascular invasion and risk category). Using the chi-square test we also evaluated the association between nodal status at retroperitoneal lymph node dissection and original vs reviewed parameters.

RESULTS

The original report did not contain vascular invasion information on 98 of 183 cases (53.4%). A total of 164 patients were evaluable since we had no slides for 19. Vascular invasion absence and presence were confirmed in 27 (73.0%) and 30 (78.9%) of 37 patients, respectively (Cohen's κ = 0.16). Low and high risk status was confirmed in 20 of 28 patients (71.4%) and in 47 of 64 (50.6%), respectively (Cohen's κ = 0.22). Reviewed vascular invasion and risk category were significantly associated with nodal status at retroperitoneal lymph node dissection (chi-square test p = 0.03 and 0.01, respectively), although the original parameters were not.

CONCLUSIONS

In half of the patients no information was available on vascular invasion in the original reports. Concordance between original and reviewed reports was generally poor. Reviewed parameters better predicted nodal status at retroperitoneal lymph node dissection. These findings may have important implications in clinical practice.

摘要

目的

我们回顾了临床 I 期非精原细胞瘤生殖细胞睾丸肿瘤患者的幻灯片,以评估原始和复查的血管侵犯状态以及其他组织学相关性之间的一致性。

材料与方法

在我们机构,2002 年至 2007 年间,202 例连续患者接受了腹膜后淋巴结清扫术。我们要求在其他地方进行睾丸切除术的 183 例患者的切片。在有血管侵犯和/或大于 90%胚胎癌的患者中,淋巴结转移的风险被认为较高,而在无血管侵犯和胚胎癌小于 90%的患者中,风险较低。使用 Cohen's κ 评估原始和复查参数(血管侵犯和风险类别)之间的一致性指数。使用卡方检验还评估了腹膜后淋巴结清扫术时的淋巴结状态与原始和复查参数之间的关系。

结果

原始报告未包含 183 例中的 98 例(53.4%)的血管侵犯信息。由于我们没有 19 例患者的切片,因此共有 164 例患者可评估。在 37 例患者中,分别有 27 例(73.0%)和 30 例(78.9%)证实了血管侵犯缺失和存在(Cohen's κ = 0.16)。在 28 例患者中,分别有 20 例(71.4%)和 47 例(50.6%)证实了低危和高危状态(Cohen's κ = 0.22)。复查的血管侵犯和风险类别与腹膜后淋巴结清扫术时的淋巴结状态显著相关(卡方检验 p = 0.03 和 0.01),尽管原始参数并非如此。

结论

在一半的患者中,原始报告中没有血管侵犯的信息。原始和复查报告之间的一致性通常较差。复查参数更好地预测了腹膜后淋巴结清扫术时的淋巴结状态。这些发现可能对临床实践具有重要意义。

相似文献

1
Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.腹膜后淋巴结清扫术后临床Ⅰ期非精原细胞瘤性生殖细胞睾丸肿瘤的原始和复查的血管侵犯和其他预后参数的一致性和预测能力。
J Urol. 2011 Oct;186(4):1298-302. doi: 10.1016/j.juro.2011.05.070. Epub 2011 Aug 17.
2
Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.腹腔镜腹膜后淋巴结清扫术治疗临床 I 期非精原细胞瘤生殖细胞肿瘤:大型单机构经验。
J Urol. 2012 Feb;187(2):487-92. doi: 10.1016/j.juro.2011.10.035. Epub 2011 Dec 16.
3
Predictors of positive retroperitoneal lymph nodes in patients with high risk testicular cancer.高危型睾丸癌患者腹膜后淋巴结阳性的预测因素。
J Urol. 2011 Dec;186(6):2245-8. doi: 10.1016/j.juro.2011.07.101. Epub 2011 Oct 19.
4
A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.一个仅用于预测接受腹膜后淋巴结清扫术的临床I期非精原细胞性生殖细胞睾丸肿瘤患者淋巴结转移情况的简单模型。
J Urol. 2004 Jan;171(1):172-6. doi: 10.1097/01.ju.0000101513.64777.f2.
5
Retroperitoneal lymph node dissection in patients with high risk testicular cancer.高危睾丸癌患者的腹膜后淋巴结清扫术
J Urol. 2009 May;181(5):2097-101; discussion 2101-2. doi: 10.1016/j.juro.2009.01.026. Epub 2009 Mar 14.
6
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.经腹膜后淋巴结清扫术治疗的临床I期非精原细胞瘤性睾丸肿瘤发生全身转移的风险
J Urol. 2000 Jun;163(6):1721-4.
7
Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.临床分期为IS期睾丸癌患者的原发性腹膜后淋巴结清扫术。
J Urol. 2009 Dec;182(6):2716-20. doi: 10.1016/j.juro.2009.08.038.
8
Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.腹膜后淋巴结清扫术治疗睾丸低分期非精原细胞瘤性生殖细胞肿瘤。
Expert Rev Anticancer Ther. 2005 Feb;5(1):75-85. doi: 10.1586/14737140.5.1.75.
9
Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion.对以胚胎癌为主和/或存在淋巴管侵犯的低分期睾丸癌患者进行腹膜后淋巴结清扫术。
J Urol. 2005 Aug;174(2):557-60; discussion 560. doi: 10.1097/01.ju.0000165163.03805.37.
10
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?在病理分期为B1的非精原细胞性生殖细胞肿瘤中,存在结外侵犯是否需要辅助化疗?
J Urol. 2007 Mar;177(3):944-6. doi: 10.1016/j.juro.2006.10.068.

引用本文的文献

1
Biomarkers of disease recurrence in stage I testicular germ cell tumours.I 期睾丸生殖细胞肿瘤疾病复发的生物标志物。
Nat Rev Urol. 2022 Nov;19(11):637-658. doi: 10.1038/s41585-022-00624-y. Epub 2022 Aug 26.
2
The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer.人工智能检测睾丸癌中淋巴管侵犯的潜力。
Cancers (Basel). 2021 Mar 16;13(6):1325. doi: 10.3390/cancers13061325.
3
Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
I 期睾丸生殖细胞肿瘤患者监测中复发的预测:生物标志物的研究。
BMC Cancer. 2020 Aug 5;20(1):728. doi: 10.1186/s12885-020-07220-6.
4
Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.淋巴血管侵犯和胚胎癌存在是临床 I 期非精原细胞瘤生殖细胞肿瘤隐匿性转移疾病的危险因素:系统评价和荟萃分析。
BJU Int. 2020 Mar;125(3):355-368. doi: 10.1111/bju.14967. Epub 2020 Jan 8.
5
Lymphovascular invasion in testicular germ cell tumors: clinicopathological correlates.睾丸生殖细胞肿瘤中的淋巴管浸润:临床病理相关性
Cent European J Urol. 2013;66(3):266-70. doi: 10.5173/ceju.2013.03.art5. Epub 2013 Nov 18.
6
Gamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.γ-谷氨酰转移酶和C反应蛋白作为代谢异常及其相关合并症的替代标志物:一项前瞻性队列研究
Int J Mol Epidemiol Genet. 2012;3(4):276-85. Epub 2012 Nov 15.
7
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.维持治疗效果、降低治疗负担、关注生存质量:第三届欧洲生殖细胞肿瘤诊断和治疗共识会议要点。
Ann Oncol. 2013 Apr;24(4):878-88. doi: 10.1093/annonc/mds579. Epub 2012 Nov 14.